H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 14.3% of adults in Rochester have diagnosed diabetes — 2.3 points above the U.S. 12% figure. Census population 211,328. New York Medicare wound biologics: National Government Services (NGS) (JK). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Rochester clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Rochester storefront.
Build Your Biologic Treatment Center in Rochester, NY for clinics & physicians. Start or expand your biolo… Compliance support & pricing — contact Hawk Medical.
Two files matter before you open a box of biologic treatment center in Rochester: (1) CDC PLACES (2023, crude) estimates 14.3% of adults in Rochester have diagnosed diabetes — 2.3 points above the U.S. 12% figure. (2) New York Part B wound biologics are reviewed by National Government Services (NGS) under JK, shared with CT, MA, ME, NH, RI, VT. We help with the second file. We do not pretend to be a Rochester storefront.
National Build Your Biologic Treatment Center notes (how the product actually works)New York shares JK with CT, MA, ME, NH, RI, VT. Florida is the only single-state MAC. CDC PLACES (2023, crude) estimates 14.3% of adults in Rochester have diagnosed diabetes — 2.3 points above the U.S. 12% figure. If you also operate in another contractor’s state, say so on the first call — we map both.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a Rochester trial. Local outcomes stay with the treating physician. CDC PLACES (2023, crude) estimates 14.3% of adults in Rochester have diagnosed diabetes — 2.3 points above the U.S. 12% figure. Use that rate for inventory math, not for ads.
CDC PLACES (2023, crude prevalence) estimates 14.3% of adults — 2.3 points above the U.S. 12% figure. Obesity is 38%; arthritis is 24.9%. That is place-level BRFSS modeling, not a clinic census and not a Rochester trial.
We do not publish a consumer directory of every account. Patients should ask their current specialist whether the practice offers build your biologic treatment center and which products they use.
No. PRP (autologous) and cellular/tissue products (allograft/skin substitutes) sit on different coding and coverage paths. National Government Services (NGS) LCDs for CTPs do not automatically cover PRP injections. Build separate protocols and fee tickets.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including New York.
Start with one protocol — one joint or one wound type — for 90 days. CDC PLACES (2023, crude) estimates 14.3% of adults in Rochester have diagnosed diabetes — 2.3 points above the U.S. 12% figure. Name a staff owner for photos, lots, and centrifuge logs. Then expand the fridge.
Contact us to learn how Hawk Medical supports practices in Rochester, NY.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Rochester is JK geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Rochester — 2.3 points above the U.S. 12% figure. Planning input, not an outcomes claim.
New York Part B wound biologics follow this contractor (siblings: CT, MA, ME, NH, RI, VT). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Rochester. Useful for joint-program math; still needs a diagnosis and privileging.
No Rochester storefront. Joe Bradley is an active practice owner. biologic treatment center stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.